A comprehensive vascular access service can reduce catheter-associated bloodstream infections and promote the appropriate use of vascular access devices

•We describe the role of a novel vascular access service in decreasing the rate of central line–associated bloodstream infections. •The reduction in central line–associated bloodstream infections was achieved by prioritizing insertion of the least invasive intravascular catheter and promoting vascular access device care and maintenance. •High-quality research is required to evaluate the impact of vascular access service in improving patient outcomes and safety. This study describes the role of a novel vascular access service in the reduction and prevention of central line–associated bloodstream infections (CLABSIs). We conducted a retrospective analysis of data obtained over a span of 24 months after implementation of our vascular access service. We identified a progressive decline in the CLABSI rate and standardized infection ratio (SIR) in 2017 (rate, 1.75; SIR, 1.25) and in 2018 (rate, 1.037; SIR, 0.91). The reduction in CLABSIs was attributed to appropriate triage, insertion, and maintenance of vascular access devices. This study describes the role of a novel vascular access service in the reduction and prevention of central line–associated bloodstream infections (CLABSIs). We conducted a retrospective analysis of data obtained over a span of 24 months after implementation of our vascular access service. We identified a progressive decline in the CLABSI rate and standardized infection ratio (SIR) in 2017 (rate, 1.75; SIR, 1.25) and in 2018 (rate, 1.037; SIR, 0.91). The reduction in CLABSIs was attributed to appropriate triage, insertion, and maintenance of vascular access devices.